• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

转运基因的单核苷酸多态性(SNP)与接受自体干细胞移植后接受马法兰治疗的多发性骨髓瘤患者口腔粘膜炎严重程度相关。

A Single Nucleotide Polymorphism (SNP) in the Transporter Gene Is Associated With the Severity of Oral Mucositis in Multiple Myeloma Patients Receiving Autologous Stem Cell Transplant Followed by Melphalan Therapy.

机构信息

Division of Pharmacy Practice and Science, College of Pharmacy, The Ohio State University, Columbus, OH, U.S.A.

Comprehensive Cancer Center, The Ohio State University, Columbus, OH, U.S.A.

出版信息

Anticancer Res. 2022 Jan;42(1):385-395. doi: 10.21873/anticanres.15497.

DOI:10.21873/anticanres.15497
PMID:34969749
Abstract

BACKGROUND

It has been reported that expression of OCT3 enhanced the sensitivity to melphalan in cells, indicative of potential roles of OCT3 in melphalan transport. Herein we investigated the association of select single nucleotide polymorphisms in SLC22A3 (gene encoding OCT3) with clinical outcomes in multiple myeloma (MM) patients with hematopoietic autologous stem cell transplants followed by high-dose melphalan therapy.

MATERIALS AND METHODS

Melphlan concentrations in blood samples from 108 MM patients were measured using liquid chromatography-tandem mass spectrometry (LC-MS/ΜS); genotypes of rs2048327, rs1810126, and rs3088442 in these patients were determined using quatitive RT-PCR assays.

RESULTS

Rs3088442 A variant-carriers had a significantly increased risk of severe oral mucositis in comparison with homozygous rs3088442 G-carriers with adjusted odds ratio of 4.00 (95% CI=1.25-14.7; p=0.027). Rs3088442 A carriers tended to have lower creatinine clearance (p=0.10) and higher maximum plasma concentration of melphalan (p=0.07).

CONCLUSION

OCT3 might be involved in melphalan transport in MM patients.

摘要

背景

有报道称,OCT3 的表达增强了细胞对美法仑的敏感性,这表明 OCT3 在美法仑转运中可能发挥作用。在此,我们研究了 SLC22A3(编码 OCT3 的基因)中选定的单核苷酸多态性与接受大剂量美法仑治疗的多发性骨髓瘤(MM)患者造血自体干细胞移植后的临床结局之间的关系。

材料和方法

采用液相色谱-串联质谱法(LC-MS/MS)测定 108 例 MM 患者血样中的美法仑浓度;采用定量 RT-PCR 法测定这些患者中 rs2048327、rs1810126 和 rs3088442 的基因型。

结果

与 rs3088442 纯合 GG 携带者相比,rs3088442 A 变异携带者发生严重口腔黏膜炎的风险显著增加,校正后的优势比为 4.00(95%CI=1.25-14.7;p=0.027)。rs3088442 A 携带者倾向于具有较低的肌酐清除率(p=0.10)和较高的美法仑最大血浆浓度(p=0.07)。

结论

OCT3 可能参与 MM 患者美法仑的转运。

相似文献

1
A Single Nucleotide Polymorphism (SNP) in the Transporter Gene Is Associated With the Severity of Oral Mucositis in Multiple Myeloma Patients Receiving Autologous Stem Cell Transplant Followed by Melphalan Therapy.转运基因的单核苷酸多态性(SNP)与接受自体干细胞移植后接受马法兰治疗的多发性骨髓瘤患者口腔粘膜炎严重程度相关。
Anticancer Res. 2022 Jan;42(1):385-395. doi: 10.21873/anticanres.15497.
2
Icing oral mucositis: Oral cryotherapy in multiple myeloma patients undergoing autologous hematopoietic stem cell transplant.冰敷口腔黏膜炎:自体造血干细胞移植的多发性骨髓瘤患者的口腔冷冻疗法
J Oncol Pharm Pract. 2017 Mar;23(2):116-120. doi: 10.1177/1078155215620920. Epub 2016 Jul 9.
3
Polymorphism in ANRIL is associated with relapse in patients with multiple myeloma after autologous stem cell transplant.ANRIL基因多态性与多发性骨髓瘤患者自体干细胞移植后的复发相关。
Mol Carcinog. 2017 Jul;56(7):1722-1732. doi: 10.1002/mc.22626. Epub 2017 Feb 16.
4
A single nucleotide polymorphism in SLC7A5 is associated with gastrointestinal toxicity after high-dose melphalan and autologous stem cell transplantation for multiple myeloma.溶质载体家族7成员5(SLC7A5)中的一个单核苷酸多态性与多发性骨髓瘤患者接受大剂量美法仑及自体干细胞移植后的胃肠道毒性相关。
Biol Blood Marrow Transplant. 2014 Jul;20(7):1014-20. doi: 10.1016/j.bbmt.2014.03.022. Epub 2014 Apr 4.
5
Cryotherapy reduces oral mucositis and febrile episodes in myeloma patients treated with high-dose melphalan and autologous stem cell transplant: a prospective, randomized study.冷冻疗法可减少接受大剂量美法仑和自体干细胞移植治疗的骨髓瘤患者的口腔黏膜炎和发热发作:一项前瞻性随机研究。
Bone Marrow Transplant. 2017 Jan;52(1):154-156. doi: 10.1038/bmt.2016.207. Epub 2016 Aug 15.
6
A Phase IIb, Multicenter, Open-Label, Safety, and Efficacy Study of High-Dose, Propylene Glycol-Free Melphalan Hydrochloride for Injection (EVOMELA) for Myeloablative Conditioning in Multiple Myeloma Patients Undergoing Autologous Transplantation.一项关于注射用高剂量、无丙二醇美法仑(EVOMELA)用于接受自体移植的多发性骨髓瘤患者清髓预处理的IIb期、多中心、开放标签、安全性和有效性研究。
Biol Blood Marrow Transplant. 2015 Dec;21(12):2100-2105. doi: 10.1016/j.bbmt.2015.08.026. Epub 2015 Aug 29.
7
Oral mucositis in myeloma patients undergoing melphalan-based autologous stem cell transplantation: incidence, risk factors and a severity predictive model.接受基于美法仑的自体干细胞移植的骨髓瘤患者的口腔黏膜炎:发病率、危险因素及严重程度预测模型
Bone Marrow Transplant. 2006 Oct;38(7):501-6. doi: 10.1038/sj.bmt.1705471.
8
GWAS of 972 autologous stem cell recipients with multiple myeloma identifies 11 genetic variants associated with chemotherapy-induced oral mucositis.对972例接受自体干细胞移植的多发性骨髓瘤患者进行的全基因组关联研究确定了11个与化疗引起的口腔黏膜炎相关的基因变异。
Support Care Cancer. 2015 Mar;23(3):841-9. doi: 10.1007/s00520-014-2406-x. Epub 2014 Sep 14.
9
Oral mucositis and outcomes of autologous hematopoietic stem-cell transplantation following high-dose melphalan conditioning for multiple myeloma.多发性骨髓瘤大剂量美法仑预处理后自体造血干细胞移植的口腔黏膜炎及预后
J Support Oncol. 2007 May;5(5):231-5.
10
A Single Nucleotide Polymorphism in Was Associated With Clinical Response in Multiple Myeloma Patients.[基因名称]中的一个单核苷酸多态性与多发性骨髓瘤患者的临床反应相关。 (你原文中“in”后面缺少具体基因名称,我先按格式补充,你可根据实际情况修改)
Anticancer Res. 2019 Jan;39(1):67-72. doi: 10.21873/anticanres.13080.

引用本文的文献

1
Prospective longitudinal analysis of clinical and immunological risk factors associated with oral and gastrointestinal mucositis following autologous stem cell transplant in adults.成人自体干细胞移植后口腔和胃肠道黏膜炎相关的临床和免疫学危险因素的前瞻性纵向分析。
Support Care Cancer. 2023 Jul 27;31(8):494. doi: 10.1007/s00520-023-07947-5.
2
Evaluating the Impacts of CYP3A4*1B and CYP3A5*3 Variations on Pharmacokinetic Behavior and Clinical Outcomes in Multiple Myeloma Patients With Autologous Stem Cell Transplant.评估 CYP3A4*1B 和 CYP3A5*3 变异对自体造血干细胞移植多发性骨髓瘤患者药代动力学行为和临床结局的影响。
Cancer Genomics Proteomics. 2023 Jan-Feb;20(1):9-17. doi: 10.21873/cgp.20360.